News
While calls for more prevention in public health strategies are increasing, in vitro diagnosis appears to be a major tool at all stages. Explanation, with Isabelle Tongio, Director of Public and Government Affairs at bioMérieux.

Swipe to discover more
-
bioMérieux - Third-Quarter 2023 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2023. Consolidated sales amounted to €2,668 million for the first nine months of 2023. -
How The Flu Can Lead to Pneumonia?
Getting the flu is no fun, but what’s even worse than the runny nose, cough, fever, and other symptoms related to the flu, is when complications arise. Pneumonia is one of the most common complications that can occur as a result of the flu. The condition can become very serious and even life-threatening. -
A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market
bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19